Next Article in Journal
Rapid, Reproducible, Quantifiable NMR Metabolomics: Methanol and Methanol: Chloroform Precipitation for Removal of Macromolecules in Serum and Whole Blood
Next Article in Special Issue
Alteration of Metabolic Pathways in Osteoarthritis
Previous Article in Journal
Reduced Plasma Levels of Very-Long-Chain Dicarboxylic Acid 28:4 in Italian and Brazilian Colorectal Cancer Patient Cohorts
Review

The Metabolome and Osteoarthritis: Possible Contributions to Symptoms and Pathology

by 1,2,* and 1,2,3,4
1
Arthritis Program, University Health Network, Toronto, ON M5T 2S8, Canada
2
Division of Genetics and Development, Krembil Research Institute, University Health Network, Toronto, ON M5T 2S8, Canada
3
Department of Surgery, University of Toronto, Toronto, ON M1C 1A4, Canada
4
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M1C 1A4, Canada
*
Author to whom correspondence should be addressed.
Metabolites 2018, 8(4), 92; https://doi.org/10.3390/metabo8040092
Received: 30 October 2018 / Revised: 7 December 2018 / Accepted: 10 December 2018 / Published: 13 December 2018
(This article belongs to the Special Issue Metabolomics of Complex Traits)
Osteoarthritis (OA) is a progressive, deteriorative disease of articular joints. Although traditionally viewed as a local pathology, biomarker exploration has shown that systemic changes can be observed. These include changes to cytokines, microRNAs, and more recently, metabolites. The metabolome is the set of metabolites within a biological sample and includes circulating amino acids, lipids, and sugar moieties. Recent studies suggest that metabolites in the synovial fluid and blood could be used as biomarkers for OA incidence, prognosis, and response to therapy. However, based on clinical, demographic, and anthropometric factors, the local synovial joint and circulating metabolomes may be patient specific, with select subsets of metabolites contributing to OA disease. This review explores the contribution of the local and systemic metabolite changes to OA, and their potential impact on OA symptoms and disease pathogenesis. View Full-Text
Keywords: metabolomics; precision medicine; osteoarthritis; local; systemic metabolomics; precision medicine; osteoarthritis; local; systemic
Show Figures

Figure 1

MDPI and ACS Style

Rockel, J.S.; Kapoor, M. The Metabolome and Osteoarthritis: Possible Contributions to Symptoms and Pathology. Metabolites 2018, 8, 92. https://doi.org/10.3390/metabo8040092

AMA Style

Rockel JS, Kapoor M. The Metabolome and Osteoarthritis: Possible Contributions to Symptoms and Pathology. Metabolites. 2018; 8(4):92. https://doi.org/10.3390/metabo8040092

Chicago/Turabian Style

Rockel, Jason S., and Mohit Kapoor. 2018. "The Metabolome and Osteoarthritis: Possible Contributions to Symptoms and Pathology" Metabolites 8, no. 4: 92. https://doi.org/10.3390/metabo8040092

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop